Mi SciELO
Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Ars Pharmaceutica (Internet)
versión On-line ISSN 2340-9894
Resumen
BUENAVIDA-JURADO, Pilar; DE LA MATTA-MARTIN, María; MARTIN-CALERO, Mª José y DE LA PUERTA-VAZQUEZ, Rocío. Strategies for detecting pharmacotherapeutic and educational needs of patients with cardiovascular risk in community pharmacy. Ars Pharm [online]. 2023, vol.64, n.3, pp.192-204. Epub 18-Dic-2023. ISSN 2340-9894. https://dx.doi.org/10.30827/ars.v64i3.27735.
Introduction:
Cardiovascular diseases are the leading cause of mortality, and community pharmacy (CP) can help patients improve modifiable cardiovascular risk factors (CVRF): hypertension (HT), dyslipidaemia, diabetes mellitus (DM), smoking, and obesity. Professional pharmaceutical services related to community health include this type of action. The aim of this study was to determine the socio-health and pharmacotherapeutic profile of patients with CVR treated in Spanish CP, to design the most effective intervention for them.
Method:
A descriptive cross-sectional study was conducted between January 2017 and February 2018. Using a data collection form, data from patients in four CP, two in Seville and two in Badajoz (Spain) were recorded through individualised interviews.
Results:
The initial sample (n=100) was reduced to 98 patients, older (61.5±10.1 years), 51.0 % male, with low educational level (53.1 %) and most of them living accompanied (87.8 %). 74.5 % were patients in primary prevention and their CVR level was moderate (2.51±1.89). Hypertension (83.7 %), dyslipidaemia (64.39 %), diabetes II (38.8 %) and obesity (52.0 %) were the most prevalent factors. Almost half of the patients (48.5 %) exercised regularly and 23.5 % were smokers. The drugs most commonly used were lipid modifiers (59.4 %), oral antidiabetics (37.5 %), antithrombotics (32.2 %) and beta-blockers (28.1 %).
Conclusions:
The use of forms aimed at detecting the educational and pharmacotherapeutic needs of CVR patients will allow one to establish different strategies to improve their ability to manage their disease.
Palabras clave : Community Pharmacy; Cardiovascular Risk; Educational Needs; Professional Pharmaceutical Services.